Unlike its pro-tumorigenic role in PanIN, NRF2 loss promoted IPMN formation through a redox-independent mechanism involving the transcriptional regulation of Spdef and Muc6, both key markers of IPMN. The gene discussed is SPDEF; the disease is pancreatic intraductal papillary-mucinous neoplasm.